AzTrials
AzTrials

Chest PainNCT02828761

Coronary Calcium Scoring Versus Standard Care for Emergency Department Chest Pain Patients

A study testing Coronary Calcium Scoring in people with Chest Pain, run by Montefiore Medical Center at 2 sites in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This research asks whether coronary calcium scoring, a non-invasive test based on computed tomography scanning, is a better way to diagnose chest pain patients than other currently used methods. Three of four patients will undergo calcium scoring and the remaining patients will receive standard care. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Chest Pain
What is being tested?
Coronary Calcium Scoring
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
2 sitesUnited States
Study dates
Jul 2023to 14 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • complaint of chest pain or pressure
  • intermediate risk by HEART score
  • clinical indication for non-invasive cardiac imaging
  • free of known coronary artery disease

Who cannot join

  • hemodynamic instability
  • electrocardiogram suggestive of acute ischemia or myocardial infarction
  • unremitting chest pain
  • serum troponin levels greater than three times the laboratory threshold
  • unable to give his/her own written, informed consent
  • pregnant women
Show all 10Show fewer
  • weight > 182 kg
  • unable to lie supine for scan
  • coronary calcium score, coronary CTA or non-contrast thoracic CT within the last year and available for review
  • unable to comply with 30 day follow-up

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Montefiore Medical Center - Einstein Division

    The Bronx, New York, 10461

  • Montefiore Medical Center - Wakefield Division

    The Bronx, New York, 10467

Other trials in United States

About this study

Official title: A Randomized Controlled Trial of Early Coronary Calcium Scoring and Standard Care in Emergency Department Chest Pain Patients

This research asks whether coronary calcium scoring, a non-invasive test based on computed tomography scanning, is a better way to diagnose chest pain patients than other currently used methods. Three of four patients will undergo calcium scoring and the remaining patients will receive standard care.

Conditions
Chest Pain
Being tested
Coronary Calcium Scoring, Standard Care
Keywords
chest pain, calcium score, coronary calcium score, coronary calcium scoring, calcium scoring, cacs, ccs
Medical subject headings
Chest Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coronary Calcium ScoringDevice

    Also called Calcium Score, Calcium Scoring, Coronary Calcium Score, CACS

    Scan with 64-detector row or better CT scanners with quantification by the Agatston method.

  • Standard CareProcedure or surgery

    Routine clinical monitoring of chest pain patients. Any of a number of non-invasive cardiac tests such as coronary CT angiography, stress echocardiography and stress radionuclide myocardial perfusion imaging may be performed.

Study groups in NCT02828761
Study groupRoleWhat they receive
Coronary Calcium ScoringExperimentalCoronary calcium scoring by multidetector row computed tomography (MDCT).
Receives: Device: Coronary Calcium Scoring
Standard CareActive comparatorStandard evaluation of chest pain patient which often includes immediate non-invasive imaging.
Receives: Procedure: Standard Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Major Adverse Cardiovascular Events

    number of patients with death, non-fatal heart attack, non-fatal stroke, non-fatal cardiac arrest

    Measured: 30 days

Secondary outcomes (1)
  1. Length of Stay

    emergency department and inpatient

    Measured: through completion of emergency department stay for each patient, an average of six hours and through completion of hospitalization, an average of two days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jul 2016 (estimated)
  2. Study startJul 2023 (estimated)
  3. Primary completion14 Sep 2023 (estimated)
  4. Study completion14 Sep 2023 (estimated)

Why it stopped: Study never initiated and formally withdrawn with the IRB on 9/14/2023.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02828761
Sponsor's protocol ID
2015-4993
Status last verified
Sep 2023
First submitted
15 Jun 2016
Last updated
15 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Coronary Calcium Scoring in people with Chest Pain, run by Montefiore Medical Center at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 15 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Major Adverse Cardiovascular Events (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in